Hildi Hagedorn

7.3k total citations · 2 hit papers
100 papers, 4.9k citations indexed

About

Hildi Hagedorn is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Hildi Hagedorn has authored 100 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in General Health Professions, 31 papers in Public Health, Environmental and Occupational Health and 26 papers in Epidemiology. Recurrent topics in Hildi Hagedorn's work include Health Policy Implementation Science (47 papers), Opioid Use Disorder Treatment (28 papers) and Primary Care and Health Outcomes (21 papers). Hildi Hagedorn is often cited by papers focused on Health Policy Implementation Science (47 papers), Opioid Use Disorder Treatment (28 papers) and Primary Care and Health Outcomes (21 papers). Hildi Hagedorn collaborates with scholars based in United States, Switzerland and Australia. Hildi Hagedorn's co-authors include Laura J. Damschroder, Jeffrey L. Smith, Amy M. Kilbourne, Mark S. Bauer, Cheryl B. Stetler, Marylou Guihan, Candice Bowman, Marcia W. Legro, Carolyn Wallace and Christian D. Helfrich and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Proceedings of the IEEE.

In The Last Decade

Hildi Hagedorn

94 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An introduction to implementation science for the non-specialist

2015 1.2k citations Mark S. Bauer, Laura J. Damschroder et al. BMC Psychology profile →
A Guide for applying a revised version of the PARIHS framework for implementation

2011 300 citations Cheryl B. Stetler, Laura J. Damschroder et al. Implementation Science profile →

Peers

Countries citing papers authored by Hildi Hagedorn

Since Specialization

Citations

This map shows the geographic impact of Hildi Hagedorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hildi Hagedorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hildi Hagedorn more than expected).

Fields of papers citing papers by Hildi Hagedorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hildi Hagedorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hildi Hagedorn. The network helps show where Hildi Hagedorn may publish in the future.

Co-authorship network of co-authors of Hildi Hagedorn

This figure shows the co-authorship network connecting the top 25 collaborators of Hildi Hagedorn. A scholar is included among the top collaborators of Hildi Hagedorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hildi Hagedorn. Hildi Hagedorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Buprenorphine Treatment for Opioid Use Disorder in Non–Addiction Specialty Settings 2025 ·JAMA Network Open ·(unknown), Audrey L. Jones, Hongwei Zhao, Richard E. Nelson, Hildi Hagedorn, Eric J. Hawkins, Adam J. Gordon	0
2	Identifying factors influencing emerging innovations in hospital discharge decision making in response to system stress: a qualitative study 2024 ·BMC Health Services Research ·Allison M. Gustavson, Matthew J. Miller, (unknown), Elizabeth Hudson, Jennifer P. Wisdom, Robert E. Burke, Hildi Hagedorn	1
3	Buprenorphine Receipt and Retention for Opioid Use Disorder Following an Initiative to Increase Access in Primary Care 2024 ·Journal of Addiction Medicine ·Eric J. Hawkins, Carol A. Malte, Hildi Hagedorn, Adam J. Gordon, Emily C. Williams, Ryan S. Trim, (unknown), (unknown), (unknown), Andrew J. Saxon	1
4	Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder 2023 ·SHILAP Revista de lepidopterología ·(unknown), Mark Bounthavong, Adam J. Gordon, Allison M. Gustavson, (unknown), W Miller, (unknown), Princess E. Ackland, Barbara Clothier, Ann Bangerter, Siamak Noorbaloochi, Alex H. S. Harris, Hildi Hagedorn	3
5	Stakeholder perceptions of using “opt-out” for tobacco use treatment in a cancer care setting: a qualitative evaluation of patients, providers, and desk staff 2023 ·SHILAP Revista de lepidopterología ·(unknown), David O. Warner, Jason S. Egginton, Hildi Hagedorn	1
6	What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities 2023 ·Journal of General Internal Medicine ·Princess E. Ackland, (unknown), Barbara Clothier, (unknown), (unknown), Adam J. Gordon, Siamak Noorbaloochi, Allison M. Gustavson, W Miller, Hildi Hagedorn	2
7	Identifying Strategies to Reduce Low-Value Preoperative Testing for Low-Risk Procedures: a Qualitative Study of Facilities with High or Recently Improved Levels of Testing 2023 ·Journal of General Internal Medicine ·Alex H. S. Harris, Andrea K. Finlay, Hildi Hagedorn, Luisa Manfredi, Gabrielle Jones, Robin N. Kamal, Erika D. Sears, Mary T. Hawn, Dan Eisenberg, Suzann Pershing, Seshadri C. Mudumbai	2
8	Adapting the Eliminating Medications Through Patient Ownership of End Results Protocol to Promote Benzodiazepine Cessation Among US Military Veterans: Focus Group Study With US Military Veterans and National Veterans Health Administration Leaders 2022 ·Journal of Medical Internet Research ·Michael A. Cucciare, Traci H. Abraham, (unknown), (unknown), (unknown), Hildi Hagedorn, Keith Humphreys	1
9	The Management of Substance Use Disorders: Synopsis of the 2021 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline 2022 ·Annals of Internal Medicine ·(unknown), Joseph Liberto, (unknown), (unknown), Hildi Hagedorn, Timothy Atkinson, James R. McKay, Larissa J. Mooney, James Sall, (unknown), (unknown), Christopher Spevak, Adam J. Gordon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	37
10	Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention (EMPOWER-ED): Randomized controlled trial protocol 2022 ·Contemporary Clinical Trials Communications ·Michael A. Cucciare, Hildi Hagedorn, Mark Bounthavong, Traci H. Abraham, Carolyn J. Greene, Xiaotong Han, (unknown), (unknown), (unknown), Keith Humphreys	1
11	Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative 2022 ·Journal of Addictions Nursing ·(unknown), (unknown), (unknown), A. Taylor Kelley, Eric J. Hawkins, Audrey L. Jones, Hildi Hagedorn, (unknown), Adam J. Gordon	9
12	Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention 2021 ·Addiction Science & Clinical Practice ·Allison M. Gustavson, (unknown), Jennifer P. Wisdom, (unknown), Princess E. Ackland, Adam J. Gordon, Hildi Hagedorn	6
13	Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration 2021 ·SHILAP Revista de lepidopterología ·Allison M. Gustavson, Jennifer P. Wisdom, (unknown), (unknown), Princess E. Ackland, Barbara Clothier, Siamak Noorbaloochi, Adam J. Gordon, Hildi Hagedorn	14
14	An introduction to implementation science for the non-specialist breakdown → 2015 ·BMC Psychology ·Mark S. Bauer, Laura J. Damschroder, Hildi Hagedorn, Jeffrey L. Smith, Amy M. Kilbourne	1177
15	Introduction to a special section on implementing evidence-based interventions for substance use disorders. 2011 ·Psychology of Addictive Behaviors ·John W. Finney, Hildi Hagedorn	8
16	A guiding framework and approach for implementation research in substance use disorders treatment. 2011 ·Psychology of Addictive Behaviors ·Laura J. Damschroder, Hildi Hagedorn	309
17	Lessons Learned about Implementing Research Evidence into Clinical Practice. 2006 ·Journal of General Internal Medicine ·Hildi Hagedorn, Mary M. Hogan, Jeffrey L. Smith, Candice Bowman, Geoffrey M. Curran, Donna Espadas, Barbara Kimmel, Laura Kochevar, Marcia W. Legro, Anne Sales	65
18	Role of "external facilitation" in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration 2006 ·Implementation Science ·Cheryl B. Stetler, Marcia W. Legro, Joanne Rycroft‐Malone, Candice Bowman, Geoffrey M. Curran, Marylou Guihan, Hildi Hagedorn, Sandra Pineros, Carolyn Wallace	306
19	Beliefs about evidence-based practices in addiction treatment: A survey of Veterans Administration program leaders 2004 ·Journal of Substance Abuse Treatment ·Jane K. Willenbring, Daniel R. Kivlahan, (unknown), (unknown), Hildi Hagedorn, Andrea Postier	65
20	Psychiatric Illness Among Drug Court Probationers 2003 ·The American Journal of Drug and Alcohol Abuse ·Hildi Hagedorn, Mark L. Willenbring	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact